Loading
Every dated change on the records linked to Locally advanced unresectable pancreatic ductal adenocarcinoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Locally advanced pancreatic cancer with chemotherapy
OS 13.
A milestone in how this cancer is treated.
Overall R0 resection rate 25 percent with chemoradiotherapy against 18 percent with chemotherapy (p 0.
OS 16.
A milestone in how this cancer is treated.